Silvercrest Asset Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Silvercrest Asset Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-769	Closed	-$6K	–	769
2019 Q3	$6K	Hold	769	–	–	﹤0.01%	728
2019 Q2	$14K	Hold	769	–	–	﹤0.01%	573
2019 Q1	$24K	Hold	769	–	–	﹤0.01%	569
2018 Q4	$23K	Hold	769	–	–	﹤0.01%	506
2018 Q3	$58K	Hold	769	–	–	﹤0.01%	534
2018 Q2	$44K	Buy	+769	New	+$28K	﹤0.01%	551

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Silvercrest Asset Management's ASXC Position: Q4 2019 in Review

Silvercrest Asset Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 769 shares — an estimated $6K sold.

Silvercrest Asset Management first reported a position in ASXC in Q2 2018 and held it in 6 quarters. The position peaked at $58K in Q3 2018. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

Silvercrest Asset Management reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
Silvercrest Asset Management sold 769 Asensus Surgical, Inc. shares in Q4 2019, an estimated $6K.
Silvercrest Asset Management first reported a position in Asensus Surgical, Inc. in Q2 2018 and held it in 6 quarters.
Silvercrest Asset Management's Asensus Surgical, Inc. position peaked at $58K in Q3 2018.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on Silvercrest Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.